Do you have this medication at home?
In addition to treating hypertension, you may also take Accupril as adjunctive therapy for the management of heart failure, when paired with diuretics and/or digitalis , according to the FDA warning. People who take Accupril for any of these conditions should check to see if their products are part of the recall.
On your bottle, look for the National Drug Code , listed on the top of the label, as well as the lot number and expiration date, listed on the lefthand side of the label. All affected products had 90 tablets each. The recalled 10-mg product has an NDC of 0071-053-23, a lot number of DR9639, and an expiration date of March 31, 2023. Recalled 20-mg products have an NDC of 0071-0532-23, lot numbers of DX8682 and DG1188, and expiration dates of March 31, 2023, and May 31, 2022, respectively. Recalled 40-mg products have an NDC of 0071-0535-23. Products from lot number DX6031 have an expiration date of March 31, 2023, while products from lot number CK6260 have an expiration date of May 31, 2022.
Recalled product lots were distributed to wholesalers and distributors across the U.S. and Puerto Rico between Dec. 2019 and April 2022, the FDA said.In the FDA announcement, Pfizer stated that Accupril's benefit/risk profile"remains positive based on currently available data" and there have been no reports of adverse events related to the recall to date.
However, if you have this recalled medication, you are advised to contact your doctors or healthcare providers about alternative treatment options. For information on returning the product and getting reimbursed, patients should also contact Sedgwick at 888-345-0481 between 8 a.m. and 5 p.m. Eastern Time, Monday through Friday.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
PTSD Symptoms Common for Family of COVID ICU Patients: StudyCOVID hardship may reach beyond the actual patient to their family, a new study finds: Family members of COVID-19 patients in intensive care may develop symptoms of anxiety, depression, and posttraumatic stress disorder.
Lire la suite »
European Committee votes in favor of common USB-C port for all devices, iPhones includedThe directive now goes to the EU Parliament and member states where Apple may be forced to go USB-C.
Lire la suite »
These Common Meds Could Be Giving You Nightmares — Best LifeIf you experience regular nightmares, your medication may be to blame—especially if you take any of these four common meds.
Lire la suite »